Abstract
Objective
To evaluate the accuracy of the 7th edition of the American Joint Committee on Cancer staging system (TNM-7) for patients undergoing hepatectomy for hepatocellular carcinoma (HCC) and to propose a modified TNM system for better prediction of survival.
Methods
Clinico-pathological data for 1,313 patients who underwent hepatectomy as initial treatment for HCC between 2000 and 2008 were retrieved from a prospective database. Overall survival (OS) and disease-free survival (DFS) were analyzed to evaluate the predictive value.
Results
The 1-, 3-, 5-year OS and DFS of 1,313 patients were 79.2, 55.4, 45.5 %, and 52.6, 36.1, 31.8 %, respectively. Multivariate analysis revealed that major vascular invasion was the most important prognostic factor for both OS and DFS, along with tumour number and size. Patients with pT1 and pT2 disease had significantly better OS and DFS than those with pT3 disease (P < 0.001). There was no significant difference between pT3a and pT4 (P = 0.552) but patients with pT3b disease had a worse OS and DFS than those with pT4 disease (P = 0.006 and P < 0.001, respectively). A modified TNM system within the existing framework was proposed to combine the current pT3a and pT4 together as the new pT3 and to change pT3b to the new pT4. Analysis showed that this modified system had a better prognostic power than either TNM-6 or TNM-7.
Conclusion
TNM-7 would seem to be inaccurate for staging advanced HCC. The modified system can improve both the prognostic accuracy and the hazard discrimination of disease to be consistent among subgroups of HCC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arii S, Yamaoka Y, Futagawa S et al (2000) Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 32(6):1224–1229
Bruix J, Llovet JM (2009) Major achievements in hepatocellular carcinoma. Lancet 373(9664):614–616
Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35(3):421–430
Chan SL, Mo FK, Johnson PJ et al (2011) Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population. J Gastroenterol Hepatol 26(2):340–347
Cheng CH, Lee CF, Wu TH et al (2011) Evaluation of the new AJCC staging system for resectable hepatocellular carcinoma. World J Surg Oncol 9:114
Choi KK, Kim SH, Choi SB et al (2011) Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma. J Gastroenterol Hepatol 26(11):1646–1651
Chun YH, Kim SU, Park JY et al (2011) Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. Eur J Cancer 47(17):2568–2575
Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474
Forner A, Reig ME, de Lope CR, Bruix J (2010) Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 30(1):61–74
Henderson JM, Sherman M, Tavill A et al (2003) AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB (Oxford) 5(4):243–250
Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90
Kee KM, Wang JH, Lee CM et al (2007) Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer 120(12):2650–2655
Kew MC (2012) Hepatocellular carcinoma in developing countries: prevention, diagnosis and treatment. World J Hepatol 4(3):99–104
Lau WY, Leung KL, Leung TW et al (1995) Resection of hepatocellular carcinoma with diaphragmatic invasion. Br J Surg 82(2):264–266
Lei HJ, Chau GY, Lui WY et al (2006) Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma. J Am Coll Surg 203(4):426–435
Li B, Yuan Y, Chen G et al (2010) Application of tumour-node-metastasis staging 2002 version in locally advanced hepatocellular carcinoma: is it predictive of surgical outcome? BMC Cancer 10:535
Lin MC, Wu CC, Chen JT et al (2005) Surgical results of hepatic resection for hepatocellular carcinoma with gross diaphragmatic invasion. Hepatogastroenterology 52(65):1497–1501
Llovet JM, Bruix J (2000) Prospective validation of the Cancer of the Liver Italian Program (CLIP) score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 32(3):679–680
Lodato F, Mazzella G, Festi D et al (2006) Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. World J Gastroenterol 12(45):7239–7249
Lu W, Dong J, Huang Z et al (2008) Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI. J Gastroenterol Hepatol 23(12):1874–1878
Marrero JA, Fontana RJ, Barrat A et al (2005) Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 41(4):707–716
Minagawa M, Ikai I, Matsuyama Y et al (2007) Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 245(6):909–922
Okuda K, Ohtsuki T, Obata H et al (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56(4):918–928
Poon RT, Fan ST, Ng IO, Wong J (2003) Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassification. Ann Surg 237(3):376–383
Shah SA, Wei AC, Cleary SP et al (2007) Prognosis and results after resection of very large (> or = 10 cm) hepatocellular carcinoma. J Gastrointest Surg 11(5):589–595
Shi J, Lai EC, Li N et al (2010) Surgical treatment of hepatocellular carcinoma with portal vein tumour thrombus. Ann Surg Oncol 17(8):2073–2080
Sobin LH, Compton CC (2010) TNM seventh edition: what’s new, what’s changed: communication from the international union against cancer and the American Joint Committee on Cancer. Cancer 116(22):5336–5339
Conflict of interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Additional information
Junting Huang and Yaojun Zhang contributed to this work equally.
Rights and permissions
About this article
Cite this article
Huang, J., Zhang, Y., Peng, Z. et al. A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy. J Cancer Res Clin Oncol 139, 1709–1719 (2013). https://doi.org/10.1007/s00432-013-1497-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-013-1497-y